Differences in relative risk for known pathogenic SNPs in BRCA2 have been previously demonstrated, and using this knowledge, patients can be enabled to make more informed decisions about their future health, with a UK study showing that the overall breast cancer SNP risk and age of onset can vary significantly between pathogenic BRCA2 SNPs [72]. The gene discussed is BRCA2; the disease is breast cancer.